Catalyst Wire Dossier Catalyst Wire Dossier

Fluzoparib

fluzoparib · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

44 regulatory and trial events tracked for Fluzoparib, covering 2017-03-07 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer [Phase 2]

See pricing